Search Results
Found 1 results
510(k) Data Aggregation
(24 days)
The StatusFirst™ Strep A is intended for use as an in vitro diagnostic product for the qualitative detection of group A streptococcal antigen directly from throat swab specimens. The test is intended for use in the physician's offices, hospitals, and clinical laboratories as an aid in the clinical diagnosis of group A streptococcal infection.
Not Found
This document is a 510(k) clearance letter for three different Strep A rapid diagnostic tests: StatusFirst™ Strep A, BioStrep® A, and BioSign® Strep A / Status AccuStrepA™. However, it does not contain the detailed study information regarding acceptance criteria and performance data. The letter only states that the devices are substantially equivalent to legally marketed predicate devices.
Therefore, I cannot provide the requested information from this document. The document primarily focuses on the regulatory clearance for the device, not the technical performance study details.
Ask a specific question about this device
Page 1 of 1